CFvantage® Cystic Fibrosis Expanded Screen

Understand what CFvantage® Cystic Fibrosis Expanded Screen signals

LOINC codes: 100694-9, 100695-6, 19146-0, 21654-9, 21656-4, 21759-6, 32624-9, 35462-1, 38404-0, 54449-4, 8266-9
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for CFvantage® Cystic Fibrosis Expanded Screen

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Prenatal Carrier Panel (CFvantage, Fragile X, SMA)

Laboratory: Quest Diagnostics
Test code: 93349
Specimen: Blood
Fasting: Not stated
LOINC: 100694-9, 100695-6, 19146-0, 21654-9, 21656-4, 21759-6, 32624-9, 35462-1, 38404-0, 54449-4, 8266-9

Laboratory assay overview

This panel identifies individuals at risk of having offspring with Cystic Fibrosis (the most common life-limiting autosomal recessive disease), Fragile X syndrome (the most common cause of inherited intellectual disability), and Spinal Muscular Atrophy (the second most common lethal autosomal recessive disease).

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 93349

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.